1
The change in EFV was significantly correlated with the change in BMI.
2
An increased incidence of adverse pregnancy outcomes was observed in the EFV group.
3
Primary endpoint was the change in EFV at 12 weeks.
4
Moreover, these mRNA expression changes correlated with trunk fat change in the EFV arm.
5
All had taken EFV for at least 4 weeks.
6
But EFV has been in trouble since it was launched more than a decade ago.
7
Understanding characteristics related to EFV success is clinically useful.
8
Conclusion: Characteristics predictive of EFV success in the short-term and longer term differed except for HxIDU.
9
Now Bruno thinks the EFV might just go the way of the Navy's recently-axed stealth destroyer.
10
The association between triglycerides and rs651821 was present with ATV-containing regimens, but not with EFV-containing regimens.
11
Women reporting that they were trying to conceive while on EFV were referred for regimen changes.
12
However the use of EFV during pregnancy remains of concern and not all national guidelines reflect WHO advice.
13
Behaviours occurring during year 1 were associated with EFV success over 5 years.
14
The objective of our study was to evaluate pregnancy outcomes in a cohort of women who conceived on EFV.
15
Still, the EFV is an "embarrassment" owing to its poor reliability and high cost, according to one Congressman.
16
Measurement of EFV levels in plasma collected at variable times after the last dose did not predict central nervous system intolerance.